FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025057. https://doi.org/10.4084/MJHID.2025.057.